Literature DB >> 23557545

Association between dyslipidemia and chronic kidney disease: a cross-sectional study in the middle-aged and elderly Chinese population.

Dong-Wei Liu1, Jia Wan, Zhang-Suo Liu, Pei Wang, Gen-Yang Cheng, Xue-Zhong Shi.   

Abstract

BACKGROUND: Dyslipidemia, a well-known risk factor for cardiovascular disease, is common in patients with kidney disease. Recent studies discerned that dyslipidemias play a critical role in renal damage progression in renal diseases, but the association between dyslipidemias and chronic kidney disease (CKD) in the general population remains unknown. Thus, we assessed whether the growing prevalence of dyslipidemia could increase the risk of CKD.
METHODS: A total of 4779 middle-aged and elderly participants participated in this study. Dyslipidemias were defined by the 2007 Guidelines in Chinese Adults. Incident CKD was defined as albuminuria and/or reduced estimated glomerular filtration rate (eGFR, < 60 ml×min(-1)×1.73 m(-2)). Regression analysis was used to evaluate the association between dyslipidemia and albuminuria/reduced eGFR.
RESULTS: Participants with hypercholesterolemia exhibited a greater prevalence of albuminuria and reduced eGFR (10.0% vs. 6.1%, P = 0.001; 4.0% vs. 2.4%, P = 0.028, respectively). Both hypercholesterolemia and low high density lipoprotein cholesterol (HDL-C) were independently associated with albuminuria (odds ratio (OR) 1.49; 95% confidence interval (CI) 1.08 - 2.07 and OR 1.53; 95%CI 1.13 - 2.09, respectively). The multivariable adjusted OR of reduced eGFR in participants with hypercholesterolemia was 1.65 (95%CI 1.03 - 2.65). As the number of dyslipidemia components increased, so did the OR of CKD: 0.87 (95%CI 0.65 - 1.15), 1.29 (95%CI, 0.83 - 2.01), and 7.87 (95%CI, 3.75 - 16.50) for albuminuria, and 0.38 (95%CI 0.21 - 0.69), 1.92 (95%CI 1.14 - 3.25), and 5.85 (95%CI 2.36 - 14.51) for reduced eGFR, respectively.
CONCLUSIONS: Our findings indicate that dyslipidemias increase the risk of CKD in the middle-aged and elderly Chinese population. Hypercholesterolemia plays an important role in reducing total eGFR. Both low HDL-C and hypercholesterolemia are associated with an increased risk for albuminuria.

Entities:  

Mesh:

Year:  2013        PMID: 23557545

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  6 in total

1.  Association between chronic hepatitis B infection and metabolic syndrome.

Authors:  Xiaohui Zhao; Drishti Shah; Usha Sambamoorthi
Journal:  J Diabetes Metab Disord       Date:  2018-10-27

2.  Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control.

Authors:  Yuanxiu Huang; Lin Gao; Xiaoping Xie; Seng Chuen Tan
Journal:  Popul Health Metr       Date:  2014-10-28

3.  Association between Obese Phenotype and Mildly Reduced eGFR among the General Population from Rural Northeast China.

Authors:  Shasha Yu; Hongmei Yang; Xiaofan Guo; Liqiang Zheng; Yingxian Sun
Journal:  Int J Environ Res Public Health       Date:  2016-05-27       Impact factor: 3.390

4.  The Association of Hypertriglyceridemic Waist Phenotype with Chronic Kidney Disease and Its Sex Difference: A Cross-Sectional Study in an Urban Chinese Elderly Population.

Authors:  Jing Zeng; Miao Liu; Lei Wu; Jianhua Wang; Shanshan Yang; Yiyan Wang; Yao Yao; Bin Jiang; Yao He
Journal:  Int J Environ Res Public Health       Date:  2016-12-13       Impact factor: 3.390

5.  Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey.

Authors:  Jiayu Duan; Chongjian Wang; Dongwei Liu; Yingjin Qiao; Shaokang Pan; Dengke Jiang; Zihao Zhao; Lulu Liang; Fei Tian; Pei Yu; Yu Zhang; Huanhuan Zhao; Zhangsuo Liu
Journal:  Sci Rep       Date:  2019-07-18       Impact factor: 4.379

6.  Urinary albumin excretion and prevalence of microalbuminuria in a general Chinese population: a cross-sectional study.

Authors:  Liuxia Yan; Jixiang Ma; Xiaolei Guo; Junli Tang; Jiyu Zhang; Zilong Lu; Huicheng Wang; Xiaoning Cai; Linhong Wang
Journal:  BMC Nephrol       Date:  2014-10-13       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.